Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one

Redox Report

Volumn 2, Issue 5, 1996, Pages 333-338

  Yamamoto, Y ^a   Kuwahara, T ^a   Watanabe, K ^b,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000393508     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1080/13510002.1996.11747069     Document Type: Article

References (18)

1. Abe K, Yuki S, Kogure K. Strong attenuation of ischemic and post-ischemic brain edema in rats by a novel free radical scavenger. Stroke 1988; 19: 480-485.
2. Nishi H, Watanabe T, Sakurai H, Yuki S, Ishibashi A. Effect of MCI-186 on brain edema in rats. Stroke 1989; 20: 1236-1240.
3. Watanabe T, Yuki S, Egawa M, Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 1994; 268: 1597-1604.
4. Watanabe T, Morita I, Nishi H, Murota S. Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukot Essent Fatty Acids 1988; 33: 81-87.
5. Nishi H, Watanabe T, Yuki S, Morinaka Y, Iseki K, Sakurai H. European Patent 208874 (1987).
6. Sachs F, Barschall H. Ueber Ketopyrazolone. Ber 1902; 35: 1437-1439.
7. Christian B, Matthias R, Edith S, Harald J. Zur Oxidation von Pyrazolinonen. J Prakt Chem 1994; 336: 70-72.
8. Ioffe I S, Kryukova L M. β-phenylhydrazone of α,β-dioxobutyric acid and its transformations. Zh Obshch Khim 1970; 40: 403-406.
9. Singleton W S, Gray M S, Brown M L, White J L. Chromatographically homogeneous lecithin from egg phospholipids. J Am Oil Chem Soc 1965; 42: 53-56.
10. Kohen R, Yamamoto Y, Cundy K C, Ames B N. Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc Natl Acad Sci USA 1988; 85: 3175-3179.
11. Jovanovic S V, Neta P, Simic M G. One-electron redox reactions of pyrazolin-5-ones. A pulse radiolysis study of antipyrine and analogues. Mol Pharmacol 1985; 28: 377-380.
12. Omelka L, Meske M, Schulz M. ESR-spektropischer Nachweis von Radikalen der 3-Methyl-pyrazplin-5-one. J Prakt Chem 1993; 335: 435-438.
13. Sevilla M D, Neta P, Marnett L J. Reaction of the antithrombotic and antimetastatic agent, Nafazatrom, with oxidizing radicals. Biochem Biophys Res Commun 1983; 115: 800-806.
14. Yamamoto Y, Wakabayashi K, Niki E, Nagao M. Comparison of plasma levels of lipid hydroperoxides and antioxidants in hyperlipidemic analbuminemic rats, Sprague-Dawley rats, and humans. Biochem Biophys Res Commun 1992; 189: 518-523.
15. Barclay L R C, Ingold K U. The autoxidation of a model membrane. A comparison of the autoxidation of egg lecithin phosphatidylcholine in water and in chlorobenzene. J Am Chem Soc 1991; 103: 6478-6485.
16. Yamamoto Y, Niki E, Kamiya Y, Shimasaki H. Oxidation of phosphatidylcholines in homogeneous solution and in water dispersion. Biochim Biophys Acta 1984; 795: 332-340.
17. Niki E. Antioxidants in relation to lipid peroxidation. Chem Phys lipids 1987; 44: 227-253.
18. Bowry V W, Stocker R. Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 1993; 115: 6029-6044.